PROCEPT BIOROBOTICS CORP. 2023-2024 Proxy Voting Records

Description as filed by funds: Election of Class III directors to serve until 2027 annual meeting of shareholders and until their successors are duly elected and qualified: Amy Dodrill

PROCEPT BIOROBOTICS CORP.’s own tally for this item (“Elect Director: Amy Dodrill”): 31,432,304 for, 7,396,713 withheld, per its Form 8-K filed June 5, 2024 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.

Reported outcome: Elected, in the filing’s own words: “All of the nominees for director listed in Proposal 1 in the Company's Definitive Proxy Statement on Schedule 14A, as filed with the Securities and Exchange Commission on April 22, 2024 (the "Proxy Statement"), were elected to serve on the Company's board of directors until the Company's 2027 annua…”
Support: 81% of votes cast — FOR ÷ (FOR + WITHHELD); abstentions and broker non-votes are excluded.

The 76 asset managers below reported 16,539,861 for, 14,611 against, 3,059,696 withheld.

Showing the 25 largest of 76 asset managers. See all 76 in the interactive database.

Description as filed by funds: Election of Class III directors to serve until 2027 annual meeting of shareholders and until their successors are duly elected and qualified: Taylor Harris

PROCEPT BIOROBOTICS CORP.’s own tally for this item (“Elect Director: Taylor Harris”): 31,484,184 for, 7,344,833 withheld, per its Form 8-K filed June 5, 2024 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.

Reported outcome: Elected, in the filing’s own words: “All of the nominees for director listed in Proposal 1 in the Company's Definitive Proxy Statement on Schedule 14A, as filed with the Securities and Exchange Commission on April 22, 2024 (the "Proxy Statement"), were elected to serve on the Company's board of directors until the Company's 2027 annua…”
Support: 81% of votes cast — FOR ÷ (FOR + WITHHELD); abstentions and broker non-votes are excluded.

The 76 asset managers below reported 16,543,118 for, 14,611 against, 3,056,439 withheld.

Showing the 25 largest of 76 asset managers. See all 76 in the interactive database.

Description as filed by funds: Election of Class III directors to serve until 2027 annual meeting of shareholders and until their successors are duly elected and qualified: Reza Zadno, Ph.D.

PROCEPT BIOROBOTICS CORP.’s own tally for this item (“Elect Director: Reza Zadno, Ph.D.”): 33,361,586 for, 5,467,431 withheld, per its Form 8-K filed June 5, 2024 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.

Reported outcome: Elected, in the filing’s own words: “All of the nominees for director listed in Proposal 1 in the Company's Definitive Proxy Statement on Schedule 14A, as filed with the Securities and Exchange Commission on April 22, 2024 (the "Proxy Statement"), were elected to serve on the Company's board of directors until the Company's 2027 annua…”
Support: 86% of votes cast — FOR ÷ (FOR + WITHHELD); abstentions and broker non-votes are excluded.

The 76 asset managers below reported 17,987,117 for, 14,611 against, 1,612,440 withheld.

Showing the 25 largest of 76 asset managers. See all 76 in the interactive database.

Description as filed by funds: Approval, on a non-binding advisory basis, of the compensation of the Company's named executive officers.

PROCEPT BIOROBOTICS CORP.’s own tally for this item (“3. A proposal to approve, on a non-binding advisory basis, the compensation of the Company's named executive officers”): 37,459,317 for, 1,254,400 withheld — passed, per its Form 8-K filed June 5, 2024 (Item 5.07).

Reported outcome: Approved, in the filing’s own words: “Proposal 3 in the Proxy Statement, a proposal to approve, on a non-binding advisory basis, the compensation of the Company's named executive officers, was approved by the following vote:”
Support: 97% of votes cast — FOR ÷ (FOR + WITHHELD); abstentions and broker non-votes are excluded.

Fund voting reports and institutional-manager reports both cover this item. An institutional manager can report shares that a fund it advises also reports, so the two are shown separately below and never added together, and their sum is not shown (fund and manager reports combined may count the same shares twice).

Fund voting reports, all 76 managers: 19,850,087 for, 7,435 against, 16,711 abstained. Showing the 25 largest; see all in the interactive database.

Institutional-manager reports, all 151 managers: 26,307,630 for, 1,134,619 against, 66,186 abstained, 685 unknown. Showing the 25 largest; see all in the interactive database.

Description as filed by funds: Ratification of the selection of PricewaterhouseCoopers LLP as the Company's Independent Registered Public Accounting Firm.

PROCEPT BIOROBOTICS CORP.’s own tally for this item (“2. A proposal to ratify the selection of PricewaterhouseCoopers LLP as the Company's independent registered public accounting firm for the year ending December 31, 2024”): 43,015,906 for, 6,635 withheld — passed, per its Form 8-K filed June 5, 2024 (Item 5.07).

Reported outcome: Approved, in the filing’s own words: “Proposal 2 in the Proxy Statement, a proposal to ratify the selection of PricewaterhouseCoopers LLP as the Company's independent registered public accounting firm for the year ending December 31, 2024, was approved by the following vote:”
Support: 99.9% of votes cast — FOR ÷ (FOR + WITHHELD); abstentions and broker non-votes are excluded.

The 75 asset managers below reported 19,597,239 for, 16,711 abstained.

Showing the 25 largest of 75 asset managers. See all 75 in the interactive database.